EML4 and lung adenocarcinoma: Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of <i>EML4-ALK</i> or <i>TPM3-ROS1</i> Fusion: A Case Report.